METHODS: VR gains more and more in importance concerning the medical area. So far it is used rudimentary for training programs mainly in endoscopic and surgery topics. We developed a program in Virtual Reality to train nurses and patients each step they need for the execution of peritoneal dialysis. RESULTS: VR allows the user to feel and act like being in a different room: he puts special glasses on and then he can look around in 360 , walk, move and interact in and with his virtual environment. Thus it is a perfect technology for educational purposes. He can virtually train different procedures he needs to do peritoneal dialysis later. Several studies showed us that the learning effect is far higher when you do things rather than only read, watch or listen to them. In VR you can combine all these different methods. In our program the nurses or patients experience the whole PD-process, get instructions and guidance and can even learn from making mistakes. They can run through the program -completely or in parts -as often as it is necessary to internalize every single step. In addition to this data from the user can be generated e.g. to improve the learning effect or to document if the training has been successfully completed. CONCLUSIONS: VR-training programs are a long-desired solution for improving the quality of the execution of peritoneal dialysis and for reducing PD-related infections drastically. They give us the possibility to standardize learning processes first for the trainers and following for the patients. Patients can learn each step in their own tempo and repeat them separately as often they need to. Mistakes can be discovered, documented and stored in everyones personal digital file. Trainers can also have a look in it. We believe, that these programs will not only reduce peritonitis rates but also make the variation between the peritonitis rates in a single country smaller.
INTRODUCTION AND AIMS:
Diabetic patients have the worst survival both on chronic hemodialysis and chronic peritoneal dialysis (CPD). The peritoneum begins to undergo morphologic changes before the start of CPD, particularly in diabetic patients. The present study was conducted to investigate the effects of diabetes on the peritoneum at the beginning of peritoneal dialysis and the impact on survival and on peritoneal ultrafiltration of these morphologic changes METHODS: We reviewed the charts of patients with endstage renal disease (ESRD) who started CPD between 1 January 2012 and 31 December 2016 in our unit and divided them into two groups: DM and nonDM. Baseline variables included demographics, kidney disease etiology, comorbidities, biochemical data (PTH, calcium, phosphate, haemoglobin), nPCR, Kt/V, daily ultrafiltration, ultrafiltration failure, hospitalizations, cardiovascular events, and peritonitis rate. At the time of CPD catheter insertion, the peritoneum was sampled to assess the presence or absence of mesothelial cell denudation, acellular sclerotic changes in submesothelial connective tissue and submesothelial connective tissue thickness. RESULTS: 97 patients, 32 (33%) diabetic and 65 (67%) nondiabetic. Compared to the nonDM group, the DM group was older (56.72616.7 years vs 52.5616.5 years, p¼ns), had a lower body mass index (BMI) (25.2464.0 kg/m2 vs 26.0464.5 kg/m2, p¼ns). All patients were free of acellular sclerotic changes of the peritoneum. Less than 35% of patients had the mesothelial layer intact. Submesothelial connective tissue thickness was significantly greater in the DM group than in the nonDM group (p < 0.02). Based on multivariate logistic regression analysis DM was associated with a significantly greater submesothelial connective tissue thickness (p < 0.032). During the average 23.8 month follow up there were no differences in the incidence of hospitalizations, cardiovascular events, or peritonitis rate between the two groups. DM had a lower Kt/V (2.2260.46 vs 2.3360.84, p¼ns), and lower PTH (4276231 pg/mL vs 5636429 pg/ mL, p¼0.046), same ultrafiltration ( 567 6460 vs 642652, p¼ns). When the anatomical findings were compared with peritoneal kinetic study no correlation was found with the presence of fibrosis. Patients have similar ultrafiltration volume. Mean actuarial (death censored) technique survival for the overall study population was 3862.09 months; in the DM and nonDM groups mean survivals were 3861.4 and 36614 months, respectively (p¼ns). During the average 23.8 month follow up, the 1, 2, and 3year survival rates in the DM group were 95.5%, 74.6%, and 63.9%, respectively, and, in the nonDM group, 98.3%, 96.2%, and 90.5%, respectively (p¼ns). CONCLUSIONS: Our findings indicate that CPD is a successful dialysis option for ESRDdiabetic patients during the first years of this renal replacement therapy, regardless of morphological changes of the peritoneum at the start of CPD.
FP508 TEMPORAL EVOLUTION IN THE SELECTION OF APD CYCLER-EMBEDDED REMOTE PATIENT MANAGEMENT FLAG ALERTS BY HEALTH CARE PRACTITIONERS (HCPS): LESSONS TO ACCELERATE THE RPM LEARNING CURVE?
Catherine Remote patient management (RPM) has been shown to impact outcomes in several chronic disease states including heart failure, hypertension, and COPD. Adoption of and adaptation to RPM in care of home patients on automated peritoneal dialysis (APD) is in its infancy. Optimal use this technology to augment patient care depends upon development by HCPs of competence and proficiency in RPM use grounded in detailed understanding of PD "cycler physiology". Progressive learning about the most clinically helpful settings should be reflected by temporal changes in selection of RPM flag alerts. This study reviews the temporal relationship between exposure to APD-RPM technology and patient monitoring flag selection by HCPs. METHODS: Extracts of historical treatment data from Jan 2016-December 2017 on 3893 European patients using a cycler with RPM capabilities (Claria APD System with Sharesource) in 169 clinics were queried from a central database. Data on clinics' selection for patient monitoring of 8 treatment flags alerts were examined at different time intervals following cycler-embedded RPM exposure. Flag rules (triggered when outside of HCP-determined range parameters) are set by each clinic and applied to all patients in that clinic. RPM flags set by clinics with less than or equal to 1 month of RPM exposure, and then at 3 month increments or quarters were determined. The measure of a clinic's experience with RPM was calculated as the difference between the time-stamps of its earliest and latest data records. Each clinic is represented once in the time category of greatest RPM use. Flag use is examined at a single point in time and represented as a percentage of clinics using that flag at that point in time. RESULTS: Frequency of flag usage was defined as high, medium or low (greater than/ equal to 70%, 50-69% and <50%, respectively) based upon the percentage of clinics using each of the flag alerts at the designated intervals. Of the 7 commonly used flags in Q4, 3 were used by less than 79% of clinics (adjusted peritoneal volume, events during treatment, and lost dwell time), 3 were used by 56-71% of clinics (drain ending early, high drain occurrence and lost treatment time), and 2 flags of lower usage (only 21-40% of clinics) were seen (initial drain variance and lost therapy volume).
CONCLUSIONS:
Temporal exposure to use of RPM is associated with differential selection of flags to monitor patient APD treatment. A snapshot of flag alerts that started and remained high were those that could indicate PD catheter effluent drain problems or affect adequacy of solute and fluid removal. Further research may suggest a HCP learning curve as to what parameters they perceive are most helpful in effectively identifying and addressing patient issues. These data may provide new HCP-RPM users with guidance and expedited learning to accelerate the proactive clinical patient management benefits offered by RPM technology. 
FP509 THE CHARACTERISTIC FINDINGS OF AGED CHRONIC PERITONEAL AND HEMO-DIALYSIS PATIENTS WITH DEMENTIA

